Pages that link to "Q27675032"
Jump to navigation
Jump to search
The following pages link to A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield (Q27675032):
Displayed 50 items.
- Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development (Q21558777) (← links)
- The HIV glycan shield as a target for broadly neutralizing antibodies (Q26786540) (← links)
- Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomics (Q26822552) (← links)
- Recent strategies targeting HIV glycans in vaccine design (Q26823603) (← links)
- Advances in structure-based vaccine design (Q26824545) (← links)
- Native functionality and therapeutic targeting of arenaviral glycoproteins (Q26827679) (← links)
- Structural insights on the role of antibodies in HIV-1 vaccine and therapy (Q26829461) (← links)
- A Blueprint for HIV Vaccine Discovery (Q26829865) (← links)
- A brief history of the global effort to develop a preventive HIV vaccine (Q26851165) (← links)
- Designing synthetic vaccines for HIV (Q26862617) (← links)
- Antibody responses to envelope glycoproteins in HIV-1 infection (Q26991572) (← links)
- HIV-1 neutralizing antibodies: understanding nature's pathways (Q27000480) (← links)
- Host-pathogen interaction in HIV infection (Q27009024) (← links)
- HIV-1 envelope glycoprotein structure (Q27011248) (← links)
- Antibodies in HIV-1 vaccine development and therapy (Q27011574) (← links)
- Virological features associated with the development of broadly neutralizing antibodies to HIV-1 (Q27025177) (← links)
- HIV broadly neutralizing antibody targets (Q27026662) (← links)
- Glycotherapy: new advances inspire a reemergence of glycans in medicine (Q27027997) (← links)
- A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen (Q27302081) (← links)
- AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity (Q27318266) (← links)
- Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells (Q27320687) (← links)
- SELMA: Selection with Modified Aptamers (Q27343053) (← links)
- Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors (Q27643993) (← links)
- Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env (Q27644383) (← links)
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 (Q27644478) (← links)
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies (Q27644515) (← links)
- Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity (Q27654848) (← links)
- Cross-neutralization of influenza A viruses mediated by a single antibody loop (Q27673206) (← links)
- Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies (Q27674878) (← links)
- Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04 (Q27675468) (← links)
- Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth (Q27676728) (← links)
- Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors (Q27677104) (← links)
- Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization (Q27677117) (← links)
- Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans (Q27678062) (← links)
- Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 (Q27678306) (← links)
- Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 (Q27678312) (← links)
- Heavy Chain-Only IgG2b Llama Antibody Effects Near-Pan HIV-1 Neutralization by Recognizing a CD4-Induced Epitope That Includes Elements of Coreceptor- and CD4-Binding Sites (Q27679031) (← links)
- Rabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected Humans (Q27679123) (← links)
- Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1 (Q27679280) (← links)
- Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer (Q27680496) (← links)
- Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer (Q27680497) (← links)
- Molecular Mechanisms of Inhibition of Influenza by Surfactant Protein D Revealed by Large-Scale Molecular Dynamics Simulation (Q27680598) (← links)
- The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies (Q27680688) (← links)
- Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus (Q27683156) (← links)
- Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike (Q27683540) (← links)
- Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers (Q27683553) (← links)
- Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization (Q27684578) (← links)
- Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface (Q27688974) (← links)
- Progress in HIV-1 vaccine development. (Q27693849) (← links)
- Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G (Q27704710) (← links)